(Q34134818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Genetic susceptibility factors for Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Richard F

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Association between an alpha(2) macroglobulin DNA polymorphism and late-onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

D Allele of the Angiotensin I–Converting Enzyme Is a Major Risk Factor for Restenosis After Coronary Stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The 5-repeat allele in the very-low-density lipoprotein receptor gene polymorphism is not increased in sporadic Alzheimer's disease in Japanese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The renin-angiotensin system in the brain: an update 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association detected between very-low-density lipoprotein receptor (VLDL-R) and late-onset Alzheimer's disease in Hong Kong Chinese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Alpha2 macroglobulin and the risk of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Metrifonate treatment of AD: influence of APOE genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Association Between Angiotensin-Converting Enzyme and Alzheimer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Clinical rationale of genetic testing in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Donepezil therapy in clinical practice: a randomized crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

APOE-epsilon4 predicts incident AD in Japanese-American men: the honolulu-asia aging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Is the LDL receptor-related protein involved in Alzheimer's disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

A familial Alzheimer's disease locus on chromosome 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Risk of Alzheimer's disease is associated with a very low-density lipoprotein receptor genotype in Northern Ireland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

The ACE gene and Alzheimer's disease susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Angiotensin converting enzyme deletion allele in different kinds of dementia disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Alzheimer's disease in Finnish twins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

APOE genotyping and response to drug treatment in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Alpha-2 macroglobulin gene and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

ApoE as a prognostic factor for post–traumatic coma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic association study between alpha 1-antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

LRP gene and late-onset Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900903-1

10.1016/S0014-2999(00)00903-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference